Literature DB >> 26498679

Radiotherapy in Gorlin Syndrome: Can It Be Safe and Effective in Adult Patients?

Sarah Baker1, Kurian Joseph2, Patricia Tai3.   

Abstract

Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare autosomal dominant disorder with multiple manifestations including early onset of cutaneous basal cell carcinomas (BCCs). Radiotherapy has traditionally been contraindicated due to reports of BCC induction. We describe here a patient treated successfully with radiotherapy with no tumour induction at 57 months of follow-up. A comprehensive literature review of radiotherapy outcomes in patients with Gorlin syndrome suggests radiotherapy may be a feasible treatment option for adult patients with treatment refractory lesions or surgical contraindication.
© The Author(s) 2015.

Entities:  

Keywords:  Gorlin syndrome; basal cell carcinoma; nevoid basal cell carcinoma syndrome; radiotherapy; secondary malignancy

Mesh:

Year:  2015        PMID: 26498679     DOI: 10.1177/1203475415612481

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  4 in total

1.  Sonidegib after vismodegib discontinuation in a patient with Gorlin-Goltz syndrome and multiple basal cell carcinomas.

Authors:  Alfredo Piccerillo; Alessandro Di Stefani; Alessio Costantini; Ketty Peris
Journal:  Dermatol Ther       Date:  2021-08-19       Impact factor: 3.858

2.  A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome).

Authors:  B J A Verkouteren; B Cosgun; M G H C Reinders; P A W K Kessler; R J Vermeulen; M Klaassens; S Lambrechts; J R van Rheenen; M van Geel; M Vreeburg; K Mosterd
Journal:  Br J Dermatol       Date:  2021-11-08       Impact factor: 11.113

3.  Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization.

Authors:  Nina B Gold; Ian M Campbell; Sarah E Sheppard; Wen-Hann Tan
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

Review 4.  Current Perspectives in the Treatment of Locally Advanced Basal Cell Carcinoma.

Authors:  Neha Gupta; Emily S Ruiz
Journal:  Drug Des Devel Ther       Date:  2022-01-14       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.